Skip to content

Main Navigation

Omniabio
  • Home
  • CDMO Services
    • Services overview
    • Platform Leadership
    • Extensive Expertise
    • Case Studies
  • Manufacturing Infrastructure
    • Infrastructure Overview
    • Facilities by project stage
  • News
    • News Releases
    • OmniaBio in the News
    • Recent Highlights
  • Events
  • Careers
  • Contact Us
  • Mailing list

OmniaBio celebrates the beginning of construction.

Posted on December 1, 2022 by jpearl

Post navigation

 Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio.NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada. 
© 2023 OmniaBio Inc.
Privacy Policy